Overview
Lung cancer care in China is supported by large thoracic surgery programs, advanced imaging, pathology, molecular testing, targeted therapy, immunotherapy, radiation oncology, and multidisciplinary tumor boards. For international patients, the key step is matching the diagnosis, stage, treatment history, and goals of care with the right specialty team.
Patient navigation focus: ChinaMedConnect helps patients prepare medical records, identify suitable hospitals, coordinate appointment requests, and understand next steps before travel.
Common Care Pathways
- Diagnostic review with CT, PET/CT, bronchoscopy, biopsy, and pathology confirmation when appropriate.
- Molecular testing for actionable mutations when clinically indicated.
- Surgical evaluation for early-stage or resectable disease, including minimally invasive thoracic surgery when appropriate.
- Medical oncology planning for targeted therapy, immunotherapy, chemotherapy, or combined approaches.
- Radiation oncology consultation for selected early-stage, locally advanced, or metastatic cases.
Questions to Ask Before Traveling
- What is the confirmed diagnosis, stage, and pathology subtype?
- Are molecular test results available in English or Chinese?
- Has a multidisciplinary tumor board reviewed the case?
- What records, imaging discs, and medication lists should be prepared?
- How will follow-up care be coordinated after returning home?
Hospitals to Consider
Depending on the case, patients may consider major cancer centers and comprehensive tertiary hospitals in Shanghai, Beijing, and Guangdong. ChinaMedConnect can help identify appropriate options based on diagnosis and treatment goals.